Improving Detection and Early Action for HPV-positive Oropharynx Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

December 15, 2022

Study Completion Date

December 31, 2024

Conditions

HPV Positive Oropharyngeal Squamous Cell Carcinoma

Interventions

DIAGNOSTIC_TEST

Blood test for HPV DNA

All participants will have blood tested for HPV DNA.

Trial Locations (1)

Brigham and Women's Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER

NCT04871490 - Improving Detection and Early Action for HPV-positive Oropharynx Cancer | Biotech Hunter | Biotech Hunter